LT3274447T - Rekombinantinio kiaulytės viruso jeryl lynn 2 pagrindo vakcina - Google Patents

Rekombinantinio kiaulytės viruso jeryl lynn 2 pagrindo vakcina

Info

Publication number: LT3274447T
Authority: LT; Lithuania
Prior art keywords: mumps virus; based vaccine; jeryl lynn; recombinant mumps; virus jeryl
Prior art date: 2015-03-27

Application number

LTEP16721253.9T

Other languages

English (en)

Inventor

Reinhard Glueck

Viviana Giannino

Gaurav Gupta

Original Assignee

Cadila Healthcare Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-03-27

Filing date

2016-03-28

Publication date

2020-02-10

2016-03-28 Application filed by Cadila Healthcare Limited filed Critical Cadila Healthcare Limited

2020-02-10 Publication of LT3274447T publication Critical patent/LT3274447T/lt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18741—Use of virus, viral particle or viral elements as a vector
- C12N2760/18743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18751—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18761—Methods of inactivation or attenuation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

LTEP16721253.9T 2015-03-27 2016-03-28 Rekombinantinio kiaulytės viruso jeryl lynn 2 pagrindo vakcina LT3274447T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN1055MU2015		2015-03-27
PCT/IN2016/000074 WO2016157208A1 (en)	2015-03-27	2016-03-28	Recombinant mumps virus jeryl lynn 2 based vaccine

Publications (1)

Publication Number	Publication Date
LT3274447T true LT3274447T (lt)	2020-02-10

Family

ID=55948921

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP16721253.9T LT3274447T (lt)	2015-03-27	2016-03-28	Rekombinantinio kiaulytės viruso jeryl lynn 2 pagrindo vakcina

Country Status (21)

Country	Link
EP (1)	EP3274447B1 (lt)
JP (2)	JP2018510642A (lt)
KR (1)	KR101970428B1 (lt)
CN (1)	CN107667175A (lt)
AR (1)	AR104271A1 (lt)
AU (1)	AU2016242460B2 (lt)
BR (1)	BR112017020643A2 (lt)
CA (1)	CA2980847C (lt)
DK (1)	DK3274447T3 (lt)
ES (1)	ES2764677T3 (lt)
HR (1)	HRP20200018T1 (lt)
HU (1)	HUE047571T2 (lt)
IL (1)	IL254698A0 (lt)
LT (1)	LT3274447T (lt)
MX (1)	MX2017012389A (lt)
PL (1)	PL3274447T3 (lt)
PT (1)	PT3274447T (lt)
RS (1)	RS59774B1 (lt)
SG (1)	SG11201707904XA (lt)
SI (1)	SI3274447T1 (lt)
WO (1)	WO2016157208A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107233576B (zh) *	2017-08-08	2020-02-07	江苏省农业科学院	耐热保护剂、猪瘟可室温保存活疫苗及其制备方法和应用
CA3080656A1 (en)	2017-10-30	2019-05-09	Baxalta GmbH	Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111218473A (zh) *	2018-11-23	2020-06-02	成都生物制品研究所有限责任公司	一种拯救腮腺炎病毒的系统和方法
CN109593784A (zh) *	2019-01-14	2019-04-09	浙江大学	一种用于拯救腮腺炎病毒的系统及拯救方法
CN109628414B (zh) *	2019-01-14	2021-03-30	浙江大学	一种mRNA甲基转移酶缺陷型腮腺炎病毒及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ276102A (en) *	1993-11-19	1998-04-27	Smithkline Beecham Biolog	Attenuated jeryl-lynn mumps virus strain and vaccines containing it
CA2333313C (en) *	1998-06-03	2011-11-08	American Cyanamid Company	Novel methods for rescue of rna viruses
CN1384877B (zh) *	1999-08-02	2010-10-27	惠氏	从cDNA拯救腮腺炎病毒
EP2298924A2 (en) *	2003-06-09	2011-03-23	Wyeth LLC	Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
CN104984352A (zh) *	2005-11-21	2015-10-21	圣诺菲·帕斯图尔有限公司	重组病毒的稳定制剂
US9821052B2 (en) *	2009-07-31	2017-11-21	Seqirus UK Limited	Reverse genetics systems

2016
- 2016-03-28 HR HRP20200018TT patent/HRP20200018T1/hr unknown
- 2016-03-28 MX MX2017012389A patent/MX2017012389A/es unknown
- 2016-03-28 PL PL16721253T patent/PL3274447T3/pl unknown
- 2016-03-28 ES ES16721253T patent/ES2764677T3/es active Active
- 2016-03-28 KR KR1020177031209A patent/KR101970428B1/ko not_active Expired - Fee Related
- 2016-03-28 HU HUE16721253A patent/HUE047571T2/hu unknown
- 2016-03-28 WO PCT/IN2016/000074 patent/WO2016157208A1/en active Application Filing
- 2016-03-28 DK DK16721253.9T patent/DK3274447T3/da active
- 2016-03-28 SG SG11201707904XA patent/SG11201707904XA/en unknown
- 2016-03-28 RS RS20200031A patent/RS59774B1/sr unknown
- 2016-03-28 JP JP2017550472A patent/JP2018510642A/ja active Pending
- 2016-03-28 CA CA2980847A patent/CA2980847C/en not_active Expired - Fee Related
- 2016-03-28 BR BR112017020643-9A patent/BR112017020643A2/pt not_active Application Discontinuation
- 2016-03-28 SI SI201630592T patent/SI3274447T1/sl unknown
- 2016-03-28 LT LTEP16721253.9T patent/LT3274447T/lt unknown
- 2016-03-28 AU AU2016242460A patent/AU2016242460B2/en not_active Ceased
- 2016-03-28 EP EP16721253.9A patent/EP3274447B1/en active Active
- 2016-03-28 CN CN201680024849.XA patent/CN107667175A/zh not_active Withdrawn
- 2016-03-28 PT PT167212539T patent/PT3274447T/pt unknown
- 2016-03-29 AR ARP160100823A patent/AR104271A1/es unknown
2017
- 2017-09-26 IL IL254698A patent/IL254698A0/en unknown
2020
- 2020-02-03 JP JP2020016274A patent/JP2020074792A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2980847A1 (en)	2016-10-06
CA2980847C (en)	2020-03-24
HUE047571T2 (hu)	2020-04-28
PT3274447T (pt)	2020-01-21
ES2764677T3 (es)	2020-06-04
AR104271A1 (es)	2017-07-12
WO2016157208A9 (en)	2017-03-16
JP2020074792A (ja)	2020-05-21
CN107667175A (zh)	2018-02-06
IL254698A0 (en)	2017-11-30
JP2018510642A (ja)	2018-04-19
AU2016242460B2 (en)	2019-04-18
MX2017012389A (es)	2018-09-19
KR101970428B1 (ko)	2019-04-18
RS59774B1 (sr)	2020-02-28
BR112017020643A2 (pt)	2018-07-17
AU2016242460A1 (en)	2017-10-19
EP3274447B1 (en)	2019-10-16
DK3274447T3 (da)	2020-01-27
WO2016157208A1 (en)	2016-10-06
HRP20200018T1 (hr)	2020-03-20
EP3274447A1 (en)	2018-01-31
KR20170131659A (ko)	2017-11-29
SG11201707904XA (en)	2017-10-30
SI3274447T1 (sl)	2020-03-31
PL3274447T3 (pl)	2021-07-19

Publication	Publication Date	Title
ZA201804071B (en)	2020-01-29	Recombinant zika vaccines
ZA201801035B (en)	2019-01-30	Vaccine compositions
IL257800A (en)	2018-04-30	Immune compositions with improved stability and immunogenicity
SMT202200361T1 (it)	2022-11-18	Vaccini contro virus respiratori
SI3393510T1 (sl)	2023-04-28	Cepivo proti virusu ZIKA
SG10201913630YA (en)	2020-03-30	Zika virus vaccine
SG11201803474UA (en)	2018-05-30	Vaccines against hepatitis b virus
GB201518684D0 (en)	2015-12-02	Vaccine
GB201613191D0 (en)	2016-09-14	Zika virus vaccine
SG11201702116VA (en)	2017-04-27	Viral rna segments as immunomodulatory agents and vaccine components
IL254698A0 (en)	2017-11-30	A vaccine based on the recombinant Jarl Lin mumps virus 2
ZA201801091B (en)	2022-07-27	Recombinant orf virus vector
GB201522132D0 (en)	2016-01-27	Vaccine
GB201506041D0 (en)	2015-05-27	Avian vaccine
GB201702193D0 (en)	2017-03-29	Hepatitis E virus vaccine
GB201504579D0 (en)	2015-05-06	Ovine vaccine
PT3393510T (pt)	2023-04-21	Vacina contra o vírus zika
HK1259941A1 (en)	2019-12-06	Respiratory virus vaccines
GB201611084D0 (en)	2016-08-10	Vaccine compositions
GB201507529D0 (en)	2015-06-17	Virus preparations